The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
lefamulin acetate · LEFAMULIN ACETATE 150 mg/15mL · Injection, Solution · Intravenous · Meitheal Pharmaceuticals Inc.
NDC 71288-0039-16 · 6 VIAL, SINGLE-USE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-USE · NDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | GAIN | Aug 19, 2029 |
| exclusivity | NCE | Aug 19, 2024 |
| patent | 12121582 | Jun 14, 2036 |
| patent | 8071643 | Mar 25, 2033 |
| patent | 8153689 | Mar 19, 2028 |
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | LEFAMULIN ACETATE 150 mg/15mL | Jul 24, 2026 | Aug 28, 2026 |
| Patheon Italia S.p.A. | LEFAMULIN ACETATE 150 mg/15mL | Jul 15, 2026 | Aug 26, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Xenleta — NDC 71288-0039-16," retrieved September 3, 2026, https://drugdashboards.com/drug/71288003916.
Free to cite with attribution — see how the data is put together.